Compare SoundHound AI Inc (SOUN) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SoundHound AI Inc vs 10X Genomics Inc — how do they compare? SoundHound AI Inc trades at $5.39 (market cap $2.45B), while 10X Genomics Inc trades at $80.65 (market cap $10.07B). The key difference: 10X Genomics Inc is far larger — about 4.1× SoundHound AI Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, SoundHound AI Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold SoundHound AI Inc for 23 Days and 10X Genomics Inc for 91 Days on average.
| SOUN | TXG | |
|---|---|---|
Market Cap | $2.45B | $10.07B |
Volume | 16,881,989 | 5,657,286 |
Sector | Technology | Health |
52-Week High | $21.40 | $97.74 |
52-Week Low | $5.52 | $11.48 |
Typical Hold Time | 23 Days | 91 Days |
Enterprise Value | $2.25B | $9.59B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SoundHound AI (SOUN) trades at $5.39, down 4.26% on the day, with the stock showing bearish technical signals despite recent earnings beats. The company maintains strong revenue growth with 2026 projections at $203M but faces significant net losses (-$137M in 2026). Analyst sentiment remains positive with a 75% buy rating and $9.33 consensus price target, while recent news highlights expansion in automotive and restaurant voice AI deployments.
The stock presents a high-risk, high-reward opportunity with strong growth potential in voice AI markets but faces profitability challenges and negative cash flow trends. Key catalysts include continued revenue expansion and new product launches, while risks include integration challenges and persistent losses requiring careful monitoring of execution milestones.
TXG trades at $80.65, up 5.98% on the day, showing strong recent momentum despite a bearish technical signal. The company reported revenue of $642.82M for 2025 with a gross margin of 70.03%, but remains unprofitable with a net loss of $43.54M. Recent news highlights the launch of the Atera spatial biology platform and a patent victory, signaling innovation and competitive strength. Analyst consensus is mixed with a $74.30 price target below the current price, indicating caution on valuation.
The outlook for TXG hinges on commercial execution of new products like Atera to drive revenue growth and a path to profitability. Investment opportunity lies in its leading technology platform and expanding market demand in genomics. Key risks include persistent losses, high valuation multiples, and competitive pressures in the life sciences tools sector. The stock's recent rally faces a test near technical resistance at $81.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SoundHound AI Inc
SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.
Read more on SOUN →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
